Hypoxemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-05-15
Clinical Trial Update: Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009) [Phase 1]
The Phase 1 trial of Frespaciguat (MK-5475) in participants with hypoxemia due to COVID-19 pneumonia has been withdrawn.